Central Lab Market Size, Share & Trends Analysis Report By Services (Genetic Services, Biomarker Services), By End-use (Pharmaceutical Companies, Biotechnology Companies), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 2 Business Days
Central Lab Market Growth & Trends
The global central lab market size is expected to reach USD 5.08 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 6.7% during the forecast period, driven by the increasing investment in R&D and increased focus of sponsors & investigators on reducing research costs. The outsourcing of central lab work is a significant factor driving the market growth.
Outsourcing central lab work is a rising trend in the clinical trial industry, which is expected to create lucrative business opportunities for central labs. The investigators and sponsors outsource ~80% of the central lab work and prefer the labs that provide end-to-end integrated services.
Investment in R&D has witnessed a surge in past years, which can be attributed to the enhanced focus on the pharmaceutical industry during the pandemic. As we enter the third year of the pandemic, investment in science has enhanced the pipeline and several clinical trials have been initiated. Over the pandemic, activity in interventional studies grew steadily. The pharmaceutical industry developed a new way of conducting trials for the management of ongoing clinical trials during the pandemic.
The pandemic has also created new growth opportunities, with an increasing focus on mRNA vaccine development and investigations for several COVID-19 treatment options. However, sample handling, supply chain, and logistics play a significant role in the sample sent to clinical labs. These samples are highly sensitive and require fast logistics with temperature control, thereby maintaining sample stability to get the most accurate results.
The rise of small- and medium-scale central laboratories is intensifying the competition globally. The presence of small- and medium-scale central labs is highly prominent in developing regions such as the Asia Pacific. These laboratories are becoming critical in the management of clinical trials globally owing to the availability of central laboratory services at 20%–35% lower prices, when compared to Europe and the U.S. Furthermore, the lower cost of conducting clinical trials in the developing economies facilitates the selection of central laboratories present in these regions, which can be attributed to lower logistic costs and presence near the trial location.
Central Lab Market Report Highlights
Central Lab Market Growth & Trends
The global central lab market size is expected to reach USD 5.08 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 6.7% during the forecast period, driven by the increasing investment in R&D and increased focus of sponsors & investigators on reducing research costs. The outsourcing of central lab work is a significant factor driving the market growth.
Outsourcing central lab work is a rising trend in the clinical trial industry, which is expected to create lucrative business opportunities for central labs. The investigators and sponsors outsource ~80% of the central lab work and prefer the labs that provide end-to-end integrated services.
Investment in R&D has witnessed a surge in past years, which can be attributed to the enhanced focus on the pharmaceutical industry during the pandemic. As we enter the third year of the pandemic, investment in science has enhanced the pipeline and several clinical trials have been initiated. Over the pandemic, activity in interventional studies grew steadily. The pharmaceutical industry developed a new way of conducting trials for the management of ongoing clinical trials during the pandemic.
The pandemic has also created new growth opportunities, with an increasing focus on mRNA vaccine development and investigations for several COVID-19 treatment options. However, sample handling, supply chain, and logistics play a significant role in the sample sent to clinical labs. These samples are highly sensitive and require fast logistics with temperature control, thereby maintaining sample stability to get the most accurate results.
The rise of small- and medium-scale central laboratories is intensifying the competition globally. The presence of small- and medium-scale central labs is highly prominent in developing regions such as the Asia Pacific. These laboratories are becoming critical in the management of clinical trials globally owing to the availability of central laboratory services at 20%–35% lower prices, when compared to Europe and the U.S. Furthermore, the lower cost of conducting clinical trials in the developing economies facilitates the selection of central laboratories present in these regions, which can be attributed to lower logistic costs and presence near the trial location.
Central Lab Market Report Highlights
- The genetic services segment is anticipated to grow at the fastest growth rate, owing to the increasing significance of genetic analysis in clinical studies
- Strategic acquisitions are one of the factors influencing the changing dynamics of the market. For instance, players are acquired by medium and large-scale enterprises for enhancing their global reach and entering new business segments
- Pharmaceutical companies held the largest market share by end-use, attributable to an increasing number of interventional studies and investment into research
- North America dominated the global market in 2021, the increasing need for genetic testing in clinical trials related to personalized healthcare in disease areas, such as diabetes & cancers
- Key players in the market include ACM Global Laboratories, Labconnect, Cerba Research, Eurofins Scientific, Medicover Integrated Clinical Services, and Versiti
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 CENTRAL LAB MARKET VARIABLES, TRENDS, & SCOPE
3.1 Central Lab Market Lineage Outlook
3.1.1 Parent Market Outlook - Clinical Laboratory Service Market
3.1.2 Ancillary Market Outlook - In Vitro Diagnostics (Ivd) Market
3.2 Penetration And Growth Prospect Mapping
3.3 Market Driver Analysis
3.3.1 Rising Investment In R&D And Clinical Trials
3.3.2 Escalating Demand For Novel Drugs
3.3.3 Outsourcing Of Central Lab Work
3.3.4 Reducing The Cost Of Drug Research
3.4 Market Restraint Analysis
3.4.1 Logistics And Sample Handling
3.5 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.6 Porter’s Five Forces Analysis
3.7 Regulatory Framework
3.8 Sme Scenario And Market Analysis
3.8.1 Demand-Side Analysis
3.8.2 Recession Analysis
3.8.3 Analysis Of Factors Influencing The Sme Space Post Pandemic
CHAPTER 4 CENTRAL LAB MARKET -SEGMENT ANALYSIS, BY SERVICE, 2018 - 2030 (USD MILLION)
4.1 Central Lab Market: Service Movement Analysis
4.1.1 Genetic Services
4.1.1.1 Genetic services market estimates and forecast, 2018 - 2030 (USD Million)
4.1.2 Biomarker Services
4.1.2.1 Biomarker services market estimates and forecast, 2018 - 2030 (USD Million)
4.1.3 Microbiology Services
4.1.3.1 Microbiology services market estimates and forecast, 2018 - 2030 (USD Million)
4.1.4 Anatomic Pathology/Histology
4.1.4.1 Anatomic pathology/histology market estimates and forecast, 2018 - 2030 (USD Million)
4.1.5 Specimen Management & Storage
4.1.5.1 Specimen management & storage market estimates and forecast, 2018 - 2030 (USD Million)
4.1.6 Special Chemistry Services
4.1.6.1 Special chemistry services market estimates and forecast, 2018 - 2030 (USD Million)
4.1.7 Others
4.1.7.1 Other services market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5 CENTRAL LAB MARKET -SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
5.1 Central Labs Market: End-use Movement Analysis
5.1.1 Pharmaceutical Companies
5.1.1.1 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
5.1.2 Biotechnology Companies
5.1.2.1 Biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
5.1.3 Academic & Research Institutes
5.1.3.1 Academic & research institutes market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6 REGIONAL BUSINESS ANALYSIS
6.1 Central Lab Market: Regional Movement Analysis
6.2 North America
6.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.4 Spain
6.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.5 France
6.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.6 Italy
6.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2 Japan
6.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.3 China
6.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.5 South Korea
6.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.6 Australia
6.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Middle East And Africa
6.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.3 United Arab Emirates
6.6.3.1 United Arab Emirates Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.4 Saudi Arabia
6.6.4.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 COMPETITIVE ANALYSIS
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.1.1 Ansoff Matrix
7.1.2 Major Deals And Strategic Alliances Analysis
7.1.2.1 Market Expansion
7.1.2.2 Product Launch
7.1.2.3 Acquisition
7.1.2.4 Partnerships And Collaborations
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Vendor Landscape
7.3.1 List Of Key Distributors And Channel Partners
7.3.2 Key Customers
7.3.3 Key Company Market Share Analysis, 2021
7.4 Public Companies
7.4.1 Company Market Position Analysis
7.4.2 Heat Map Analysis
7.4.3 Regional Network Map
7.4.4 Competitive Dashboard Analysis
7.4.4.1 Market Differentiators
7.5 Private Companies
7.5.1 List Of Key Emerging Companies
7.5.2 Heat Map Analysis
7.5.3 Regional Network Map
7.6 Company Profiles
7.6.1 ACM GLOBAL LABORATORIES
7.6.1.1 Company overview
7.6.1.2 Product benchmarking
7.6.1.3 Strategic initiatives
7.6.2 LABCONNECT
7.6.2.1 Company overview
7.6.2.2 Product benchmarking
7.6.2.3 Strategic initiatives
7.6.3 CERBA RESEARCH
7.6.3.1 Company overview
7.6.3.2 Product benchmarking
7.6.3.3 Strategic initiatives
7.6.4 EUROFINS SCIENTIFIC
7.6.4.1 Company overview
7.6.4.2 Financial performance
7.6.4.3 Product benchmarking
7.6.5 MEDICOVER INTEGRATED CLINICAL SERVICES
7.6.5.1 Company overview
7.6.5.2 Synevo Central Labs
7.6.5.3 Financial performance
7.6.5.4 Product benchmarking
7.6.6 VERSITI
7.6.6.1 Company overview
7.6.6.2 Cenetron
7.6.6.3 Product benchmarking
7.6.6.4 Strategic initiatives
7.6.7 A.P. M?LLER HOLDING A/S
7.6.7.1 Company overview
7.6.7.2 Unilabs
7.6.7.3 Company overview
7.6.7.4 Financial performance
7.6.7.5 Product benchmarking
7.6.7.6 Strategic initiatives
7.6.8 AMPERSAND CAPITAL PARTNERS
7.6.8.1 Company overview
7.6.8.2 Pacific Biomarkers
7.6.8.3 Company overview
7.6.8.4 Product benchmarking
7.6.8.5 Strategic initiatives
7.6.9 LAMBDA THERAPEUTICS RESEARCH LTD.
7.6.9.1 Company overview
7.6.9.2 Product benchmarking
7.6.9.3 Strategic initiatives
7.6.10 CIRION BIOPHARMA RESEARCH INC.
7.6.10.1 Company overview
7.6.10.2 Product benchmarking
7.6.10.3 Strategic initiatives
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 CENTRAL LAB MARKET VARIABLES, TRENDS, & SCOPE
3.1 Central Lab Market Lineage Outlook
3.1.1 Parent Market Outlook - Clinical Laboratory Service Market
3.1.2 Ancillary Market Outlook - In Vitro Diagnostics (Ivd) Market
3.2 Penetration And Growth Prospect Mapping
3.3 Market Driver Analysis
3.3.1 Rising Investment In R&D And Clinical Trials
3.3.2 Escalating Demand For Novel Drugs
3.3.3 Outsourcing Of Central Lab Work
3.3.4 Reducing The Cost Of Drug Research
3.4 Market Restraint Analysis
3.4.1 Logistics And Sample Handling
3.5 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
3.6 Porter’s Five Forces Analysis
3.7 Regulatory Framework
3.8 Sme Scenario And Market Analysis
3.8.1 Demand-Side Analysis
3.8.2 Recession Analysis
3.8.3 Analysis Of Factors Influencing The Sme Space Post Pandemic
CHAPTER 4 CENTRAL LAB MARKET -SEGMENT ANALYSIS, BY SERVICE, 2018 - 2030 (USD MILLION)
4.1 Central Lab Market: Service Movement Analysis
4.1.1 Genetic Services
4.1.1.1 Genetic services market estimates and forecast, 2018 - 2030 (USD Million)
4.1.2 Biomarker Services
4.1.2.1 Biomarker services market estimates and forecast, 2018 - 2030 (USD Million)
4.1.3 Microbiology Services
4.1.3.1 Microbiology services market estimates and forecast, 2018 - 2030 (USD Million)
4.1.4 Anatomic Pathology/Histology
4.1.4.1 Anatomic pathology/histology market estimates and forecast, 2018 - 2030 (USD Million)
4.1.5 Specimen Management & Storage
4.1.5.1 Specimen management & storage market estimates and forecast, 2018 - 2030 (USD Million)
4.1.6 Special Chemistry Services
4.1.6.1 Special chemistry services market estimates and forecast, 2018 - 2030 (USD Million)
4.1.7 Others
4.1.7.1 Other services market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5 CENTRAL LAB MARKET -SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
5.1 Central Labs Market: End-use Movement Analysis
5.1.1 Pharmaceutical Companies
5.1.1.1 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
5.1.2 Biotechnology Companies
5.1.2.1 Biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
5.1.3 Academic & Research Institutes
5.1.3.1 Academic & research institutes market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6 REGIONAL BUSINESS ANALYSIS
6.1 Central Lab Market: Regional Movement Analysis
6.2 North America
6.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.4 Spain
6.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.5 France
6.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.6 Italy
6.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.2 Japan
6.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.3 China
6.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.5 South Korea
6.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4.6 Australia
6.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Middle East And Africa
6.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.3 United Arab Emirates
6.6.3.1 United Arab Emirates Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6.4 Saudi Arabia
6.6.4.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 7 COMPETITIVE ANALYSIS
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.1.1 Ansoff Matrix
7.1.2 Major Deals And Strategic Alliances Analysis
7.1.2.1 Market Expansion
7.1.2.2 Product Launch
7.1.2.3 Acquisition
7.1.2.4 Partnerships And Collaborations
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Vendor Landscape
7.3.1 List Of Key Distributors And Channel Partners
7.3.2 Key Customers
7.3.3 Key Company Market Share Analysis, 2021
7.4 Public Companies
7.4.1 Company Market Position Analysis
7.4.2 Heat Map Analysis
7.4.3 Regional Network Map
7.4.4 Competitive Dashboard Analysis
7.4.4.1 Market Differentiators
7.5 Private Companies
7.5.1 List Of Key Emerging Companies
7.5.2 Heat Map Analysis
7.5.3 Regional Network Map
7.6 Company Profiles
7.6.1 ACM GLOBAL LABORATORIES
7.6.1.1 Company overview
7.6.1.2 Product benchmarking
7.6.1.3 Strategic initiatives
7.6.2 LABCONNECT
7.6.2.1 Company overview
7.6.2.2 Product benchmarking
7.6.2.3 Strategic initiatives
7.6.3 CERBA RESEARCH
7.6.3.1 Company overview
7.6.3.2 Product benchmarking
7.6.3.3 Strategic initiatives
7.6.4 EUROFINS SCIENTIFIC
7.6.4.1 Company overview
7.6.4.2 Financial performance
7.6.4.3 Product benchmarking
7.6.5 MEDICOVER INTEGRATED CLINICAL SERVICES
7.6.5.1 Company overview
7.6.5.2 Synevo Central Labs
7.6.5.3 Financial performance
7.6.5.4 Product benchmarking
7.6.6 VERSITI
7.6.6.1 Company overview
7.6.6.2 Cenetron
7.6.6.3 Product benchmarking
7.6.6.4 Strategic initiatives
7.6.7 A.P. M?LLER HOLDING A/S
7.6.7.1 Company overview
7.6.7.2 Unilabs
7.6.7.3 Company overview
7.6.7.4 Financial performance
7.6.7.5 Product benchmarking
7.6.7.6 Strategic initiatives
7.6.8 AMPERSAND CAPITAL PARTNERS
7.6.8.1 Company overview
7.6.8.2 Pacific Biomarkers
7.6.8.3 Company overview
7.6.8.4 Product benchmarking
7.6.8.5 Strategic initiatives
7.6.9 LAMBDA THERAPEUTICS RESEARCH LTD.
7.6.9.1 Company overview
7.6.9.2 Product benchmarking
7.6.9.3 Strategic initiatives
7.6.10 CIRION BIOPHARMA RESEARCH INC.
7.6.10.1 Company overview
7.6.10.2 Product benchmarking
7.6.10.3 Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Regulatory and reimbursement framework
Table 4 Leading market players anticipated witnessing highest growth
Table 5 Global Clinical Laboratory Services Market, By Region, 2017 - 2028 (USD Billion)
Table 7 Global Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 8 Global Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 9 North America Clinical Laboratory Services Market, By Country, 2017 - 2028 (USD Billion)
Table 10 North America Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 11 North America Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 12 U.S. Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 13 U.S. Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 14 Canada Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 15 Canada Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 16 Europe Clinical Laboratory Services Market, By Country, 2017 - 2028 (USD Billion)
Table 17 Europe Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 18 Europe Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 19 U.K. Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 20 U.K. Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 21 Germany Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 22 Germany Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 23 France Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 24 France Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 25 Italy Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 26 Italy Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 27 Spain Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 28 Spain Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 29 Asia Pacific Clinical Laboratory Services Market, By Country, 2017 - 2028 (USD Billion)
Table 30 Asia Pacific Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 31 Asia Pacific Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 32 Japan Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 33 Japan Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 34 China Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 35 China Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 36 India Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 37 India Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 38 Australia Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 39 Australia Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 40 South Korea Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 41 South Korea Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 42 Latin America Clinical Laboratory Services Market, By Country, 2017 - 2028 (USD Billion)
Table 43 Latin America Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 44 Latin America Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 45 Brazil Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 46 Brazil Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 47 Mexico Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 48 Mexico Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 49 Argentina Clinical Laboratory Services Market, By Test Type, 2017 - 2028 (USD Billion)
Table 50 Argentina Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 51 Argentina Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 52 Middle East & Africa Clinical Laboratory Services Market, By Country, 2017 - 2028 (USD Billion)
Table 53 Middle East & Africa Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 54 Middle East & Africa Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 55 South Africa Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 56 South Africa Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 57 Saudi Arabia Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 58 Saudi Arabia Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 59 UAE Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 60 UAE Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Regulatory and reimbursement framework
Table 4 Leading market players anticipated witnessing highest growth
Table 5 Global Clinical Laboratory Services Market, By Region, 2017 - 2028 (USD Billion)
Table 7 Global Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 8 Global Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 9 North America Clinical Laboratory Services Market, By Country, 2017 - 2028 (USD Billion)
Table 10 North America Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 11 North America Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 12 U.S. Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 13 U.S. Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 14 Canada Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 15 Canada Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 16 Europe Clinical Laboratory Services Market, By Country, 2017 - 2028 (USD Billion)
Table 17 Europe Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 18 Europe Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 19 U.K. Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 20 U.K. Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 21 Germany Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 22 Germany Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 23 France Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 24 France Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 25 Italy Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 26 Italy Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 27 Spain Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 28 Spain Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 29 Asia Pacific Clinical Laboratory Services Market, By Country, 2017 - 2028 (USD Billion)
Table 30 Asia Pacific Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 31 Asia Pacific Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 32 Japan Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 33 Japan Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 34 China Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 35 China Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 36 India Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 37 India Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 38 Australia Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 39 Australia Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 40 South Korea Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 41 South Korea Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 42 Latin America Clinical Laboratory Services Market, By Country, 2017 - 2028 (USD Billion)
Table 43 Latin America Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 44 Latin America Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 45 Brazil Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 46 Brazil Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 47 Mexico Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 48 Mexico Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 49 Argentina Clinical Laboratory Services Market, By Test Type, 2017 - 2028 (USD Billion)
Table 50 Argentina Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 51 Argentina Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 52 Middle East & Africa Clinical Laboratory Services Market, By Country, 2017 - 2028 (USD Billion)
Table 53 Middle East & Africa Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 54 Middle East & Africa Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 55 South Africa Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 56 South Africa Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 57 Saudi Arabia Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 58 Saudi Arabia Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
Table 59 UAE Clinical Laboratory Services Market, By Services, 2017 - 2028 (USD Billion)
Table 60 UAE Clinical Laboratory Services Market, By End-use, 2017 - 2028 (USD Billion)
LIST OF FIGURES
Fig. 1 Central lab market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Central lab market snapshot
Fig. 10 Penetration and growth prospect mapping
Fig. 11 Central lab market driver impact
Fig. 12 Central lab market restraint impact
Fig. 13 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 14 Porter’s five forces analysis
Fig. 15 Where are clinical trials being conducted
Fig. 16 Taking control of changing regulatory landscape
Fig. 17 Consumer analysis
Fig. 18 Entry into new markets
Fig. 19 Central labs market : End-use outlook and key takeaways
Fig. 20 Central labs market : End-use movement analysis
Fig. 21 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Academic & research institutes market estimates and forecast,, 2018 - 2030 (USD Million)
Fig. 24 Central lab market : Regional outlook and key takeaways
Fig. 25 Central lab market : Regional movement analysis
Fig. 26 North America
Fig. 27 North America. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 U.S.
Fig. 29 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Canada
Fig. 31 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Europe
Fig. 33 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 U.K.
Fig. 35 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Germany
Fig. 37 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Spain
Fig. 39 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 France
Fig. 41 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Italy
Fig. 43 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Asia Pacific
Fig. 45 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Japan
Fig. 47 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 China
Fig. 49 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 India
Fig. 51 India. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 South Korea
Fig. 53 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Australia
Fig. 55 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Latin America
Fig. 57 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Brazil
Fig. 59 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Mexico
Fig. 61 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Argentina
Fig. 63 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Middle East & Africa
Fig. 65 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 South Africa
Fig. 67 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 United Arab Emirates
Fig. 69 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Saudi Arabia
Fig. 71 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Ansoff matrix
Fig. 73 Strategy mapping
Fig. 74 Company market share analysis, 2021
Fig. 75 Company market position analysis
Fig. 76 Company market position analysis
Fig. 77 Heat Map Analysis
Fig. 78 Regional Network Map
Fig. 79 Market differentiators
Fig. 80 Heat Map Analysis
Fig. 81 Regional Network Map
Fig. 1 Central lab market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Central lab market snapshot
Fig. 10 Penetration and growth prospect mapping
Fig. 11 Central lab market driver impact
Fig. 12 Central lab market restraint impact
Fig. 13 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 14 Porter’s five forces analysis
Fig. 15 Where are clinical trials being conducted
Fig. 16 Taking control of changing regulatory landscape
Fig. 17 Consumer analysis
Fig. 18 Entry into new markets
Fig. 19 Central labs market : End-use outlook and key takeaways
Fig. 20 Central labs market : End-use movement analysis
Fig. 21 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Academic & research institutes market estimates and forecast,, 2018 - 2030 (USD Million)
Fig. 24 Central lab market : Regional outlook and key takeaways
Fig. 25 Central lab market : Regional movement analysis
Fig. 26 North America
Fig. 27 North America. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 U.S.
Fig. 29 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Canada
Fig. 31 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Europe
Fig. 33 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 U.K.
Fig. 35 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Germany
Fig. 37 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Spain
Fig. 39 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 France
Fig. 41 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Italy
Fig. 43 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Asia Pacific
Fig. 45 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Japan
Fig. 47 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 China
Fig. 49 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 India
Fig. 51 India. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 South Korea
Fig. 53 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Australia
Fig. 55 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Latin America
Fig. 57 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Brazil
Fig. 59 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Mexico
Fig. 61 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Argentina
Fig. 63 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Middle East & Africa
Fig. 65 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 South Africa
Fig. 67 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 United Arab Emirates
Fig. 69 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Saudi Arabia
Fig. 71 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Ansoff matrix
Fig. 73 Strategy mapping
Fig. 74 Company market share analysis, 2021
Fig. 75 Company market position analysis
Fig. 76 Company market position analysis
Fig. 77 Heat Map Analysis
Fig. 78 Regional Network Map
Fig. 79 Market differentiators
Fig. 80 Heat Map Analysis
Fig. 81 Regional Network Map
